At SIGA, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.
View Top Employees from SIGA TechnologiesWebsite | http://www.siga.com |
Ticker | SIGA |
Revenue | $139.4 million |
Funding | $12.5 million |
Employees | 94 (69 on RocketReach) |
Founded | 1995 |
Address | 27 East 62nd Street, New York, New York 10065, US |
Phone | (212) 672-9100 |
Fax | (212) 697-3130 |
Technologies |
JavaScript,
HTML,
PHP
+47 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering |
Web Rank | 5 Million |
Keywords | St-246 Smallpox Fda, Siga Technologies R Abrams, Siga Pec Llc New York, Siga Technologies คือ |
Competitors | Chimerix, Inc., Cocrystal Pharma, Inc., Microbiotix, Inc, Sequella, Inc., Venatorx Pharmaceuticals, Inc. |
SIC | SIC Code 87 Companies, SIC Code 28 Companies, SIC Code 873 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular SIGA Technologies employee's phone or email?
The SIGA Technologies annual revenue was $139.4 million in 2024.
Jay Varma is the Executive Vice President, Chief Medical Officer of SIGA Technologies.
69 people are employed at SIGA Technologies.
SIGA Technologies is based in New York, New York.
The NAICS codes for SIGA Technologies are [32, 325, 3254, 32541].
The SIC codes for SIGA Technologies are [87, 28, 873, 283].